Royalty Pharma
RPRX
#874
Rank
S$35.66 B
Marketcap
S$61.65
Share price
1.11%
Change (1 day)
46.48%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: S$35.66 Billion

As of April 2026 Royalty Pharma has a market cap of S$35.66 Billion. This makes Royalty Pharma the world's 874th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$35.66 B21.44%
2025S$29.36 B43.57%
2024S$20.45 B-8.05%
2023S$22.24 B-4.82%
2022S$23.36 B1%
2021S$23.13 B-9.96%
2020S$25.69 B

End of Day market cap according to different sources

On Apr 12th, 2026 the market cap of Royalty Pharma was reported to be:

S$35.17 Billion
by Nasdaq info icon info icon
S$35.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
S$222.73 B 524.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.059 T 2,869.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$2.26 B-93.64%๐Ÿ‡บ๐Ÿ‡ธ USA